ResearcherOkayama UniversityNo recent work listed
Ryo Harada
Matched on ORCID iD 0000-0002-7213-8661; OpenAlex author ID A5041635125. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- [Venous thromboembolism and risk factors for deep vein thrombosis in patients with pancreatic cancer undergoing chemotherapy]. Last author DOI 10.11405/nisshoshi.120.755↗
- Effectiveness of an Oral Elemental Diet for Patients With Unresectable Pancreatic Cancer: a Prospective Cohort Study First author DOI 10.21203/rs.3.rs-1244457/v1↗
- A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensit… Co-author DOI 10.1007/s10147-011-0237-z↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kentaro Oki · 1 shared paper, 2023 · strength 0.26
- Hironari Kato · 2 shared papers, 2011–2022 · strength 0.17
- Paper Effectiveness of an Oral Elemental Diet for Patients With Unresectable Pancreatic Cancer: a Prospective Cohort Study DOI 10.21203/rs.3.rs-1244457/v1↗
- Paper A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II stud… DOI 10.1007/s10147-011-0237-z↗
- Hitomi Himei · 1 shared paper, 2022 · strength 0.15
- Shigeru Horiguchi · 1 shared paper, 2022 · strength 0.15
- Ryosuke Sato · 1 shared paper, 2022 · strength 0.15
- Hiroyuki Okada · 1 shared paper, 2022 · strength 0.15
- Ken Hirao · 1 shared paper, 2011 · strength 0.02
- Koichiro Tsutsumi · 1 shared paper, 2011 · strength 0.02
- Hirofumi Kawamoto · 1 shared paper, 2011 · strength 0.02
- Kazuhide Yamamoto · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.